GSK3B and breast carcinoma: For instance, increased phosphorylation of GSK3β (Ser9) is observed in cisplatin-resistant ovarian cancer cells44, while inhibition of GSK3β activity contributes to drug resistance in breast cancer cells45 and neuroblastoma cells46.